Comment on Lundeen et al. Trends in the Prevalence and Treatment of Diabetic Macular Edema and Vision-Threatening Diabetic Retinopathy Among Commercially Insured Adults Aged <65 Years. Diabetes Care 2023;46:687-696

Diabetes Care. 2023 Jul 1;46(7):e138-e139. doi: 10.2337/dc23-0588.
No abstract available

Publication types

  • Comment

MeSH terms

  • Adult
  • Cross-Sectional Studies
  • Diabetes Mellitus*
  • Diabetic Retinopathy* / epidemiology
  • Diabetic Retinopathy* / therapy
  • Humans
  • Macular Edema* / epidemiology
  • Macular Edema* / therapy
  • Prevalence